Google Health takes strategic stake in Flo Health in women's health push
What's the deal? Flo Health has secured a strategic investment from Google HealthDealroom has a profile for this one. Try Dealroom → as part of a multi-year partnership to integrate women's health data into wearable fitness tracking. The deal pairs Flo, which says half a billion people have downloaded its app and more than 80 million women use it monthly, with Google's wearables and coaching tools.
What's the endgame? Starting in early 2027, users who opt in can sync Flo with Google HealthDealroom has a profile for this one. Try Dealroom →, feeding Fitbit signals — sleep, heart rate, heart rate variability, skin temperature, and respiratory rate — into Flo for sharper cycle predictions. In return, Flo's insights will inform Google Health Coach, and Flo will be the featured women's health partner inside the Google Health app.
What else is coming? The two plan co-branded products built for women, combining Flo's algorithms with Google's wearable hardware. They will also launch a joint research programme to build AI that better understands how hormones affect sleep, mood, and energy — and to spot early signs of perimenopause and conditions such as PCOS, endometriosis, and fibroids, which can take years to diagnose.
Why now? Women's health has long been under-researched, and the companies argue AI risks inheriting those gaps. "Women have waited too long," the firms said, framing the deal as a correction to that neglect.
What could go wrong? Health data is sensitive, and the partnership hinges on user trust. Both companies say no data moves between apps without explicit, per-purpose permission that users can withdraw at any time, and that Flo data shared with Google Health will never be used for advertising, sold, or passed to other developers. Flo remains an independent company.
The signal: A decade after launch, Flo is moving from standalone app to the women's health layer inside one of the largest wearable ecosystems. For Google, the deal is a bet that personalised, cycle-aware tracking is central to the next phase of consumer health — and that getting women's data right is table stakes.
Read more: blog.google, linkedin.com, prnewswire.com
Image credit: Generated with Gemini
